{
  "abstract": "Purpose Antinuclear valosin-containing protein-like protein (NVL) antibodies have been detected only in systemic sclerosis (SSc) patients, and diverse comorbidities have been reported in anti-NVL antibody-positive SSc patients. Any relationship between antibodies against NVL1, a minor isoform of NVL, and the clinical symptoms also remains unclear. To clarify the clinical features of anti-NVL2 antibody-positive patients, we developed an ELISA for measuring antibodies against NVL2, a major target of autoantibodies against NVL.Methods Sera from 1676 patients with various conditions were included. 167 anti-nucleolar antibody (ANoA)-positive sera, 120 ANoA-negative sera and 17 healthy control sera were examined by an ELISA that uses the recombinant protein of NVL2 derived from its gene-manipulated complementary DNA clone (modified NVL2 (mNVL2)).Results 18 ANoA-positive sera subjected to indirect immunofluorescence (IIF) were positive for anti-mNVL2 ELISA. Although one ANoA-negative serum was judged false positive in our anti-mNVL2 ELISA, the above 18 anti-mNVL2 ELISA-positive sera were confirmed to be positive for anti-NVL2 antibodies by immunoprecipitation-Western blotting. Anti-NVL2 antibodies were detected in 17.0% of homogeneous nucleolar (AC-8) patterns in IIF. Six SSc patients had anti-NVL2 antibodies, whereas five with idiopathic interstitial pneumonia and seven with other diseases had anti-NVL2 antibodies. Anti-mNVL2 ELISA titres were significantly higher in the anti-NVL2 antibody-positive SSc patients than in the anti-NVL2 antibody-positive non-SSc patients (p<0.042).Conclusions We found more anti-NVL2 antibody-positive cases than any previous study, as far as we know. Our ELISA, which showed an association between titres of these antibodies and SSc diagnosis, promises to expand knowledge about anti-NVL2 antibodies.",
  "authors": [
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Yuta Yamashita"
    },
    {
      "affiliations": [
        "Respiratory and Allergy Medicine, Tosei General Hospital, Seto, Japan"
      ],
      "name": "Yasuhiko Yamano"
    },
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Yoshinao Muro"
    },
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Haruka Koizumi"
    },
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Mariko Ogawa-Momohara"
    },
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Satoshi Kamiya"
    },
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Norika Akashi"
    },
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Takuya Takeichi"
    },
    {
      "affiliations": [
        "Respiratory and Allergy Medicine, Tosei General Hospital, Seto, Japan"
      ],
      "name": "Yasuhiro Kondoh"
    },
    {
      "affiliations": [
        "Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
      ],
      "name": "Masashi Akiyama"
    }
  ],
  "title": "Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA",
  "uid": "926a98d8-0f37-5c73-b03e-c46d94825c10"
}